1990 results found

Blessing Hospital recognized nationally for patient safety

An independent national healthcare organization has given Blessing Hospital its top grade for patient safety. The Leapfrog Group gave the hospital a grade “A” for the fall 2024 national survey period. Blessing was among fewer than 30% of hospitals nationwide and one of only 32 hospitals in Illinois to receive the top grade.

Long-time Blessing nurse retires

Sheila Williamson, LPN, Payor/Placement Specialist, Patient Access department, Blessing Hospital, retires January 11 after 44 years of service.

Blessing Hospital earns fifth straight top safety score

For the fifth consecutive survey period, an independent national healthcare watchdog organization has given Blessing Hospital a grade of “A” for patient safety.

Respiratory therapy team chooses its top performer for the year

Dakota Nuyen, registered respiratory therapist, Blessing Hospital, received the 2024 RT Excellence award based on her nomination by a coworker Desiree Singh.

Blessing nurse retires after 38 year career

Cathy Aschemann, RN, BSN, clinical documentation specialist, Health Information Management department, Blessing Hospital, retired on Friday, February 19, after 38 years of service.

Blessing Health medical assistant retires

Marilyn Valentine, registered medical assistant, Hamilton Warsaw Clinic, Blessing Health, retired June 7, 2024, after 12 years of service.

New care option available for uncontrolled high blood pressure

People living with uncontrolled high blood pressure, known as resistant hypertension, have a new treatment option from Blessing Health.

Long-time Blessing Hospital nurse retires

Jill Cantrell, BSN, RN, MDS coordinator, Skilled Nursing Unit, Blessing Hospital, retires on June 14, 2024, after 48 year of service.

Rehab staffer earns Honey Bee award

Blessing participates in new cancer treatment trial

The Blessing Cancer Center has been selected as one of 51 study locations worldwide participating in a new metastatic breast cancer clinical trial. Metastatic cancer has traveled to other parts of the body from its site of origination. It is estimated that 20-30 percent of all breast cancer cases will become metastatic. The clinical trial is studying the effectiveness, safety and tolerability of a first-of-its-kind medication, Enobosarm.